TY - JOUR T1 - Hearing aids reduce daily-life fatigue and increase social activity: a longitudinal study JF - medRxiv DO - 10.1101/2021.05.05.21255749 SP - 2021.05.05.21255749 AU - Jack A. Holman AU - Avril Drummond AU - Graham Naylor Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/10/2021.05.05.21255749.abstract N2 - People with hearing loss experience fatigue, and it is unknown whether this is alleviated by treatment with hearing aids. The objective of this study was to address this issue, and to investigate the possible concomitant effect of hearing-aid fitting on activity levels. An intervention group (n=53) who were due to be fitted with their first ever hearing aid(s) and a control group (n=53) who had hearing loss but no change in hearing aid status completed a battery of self-report outcome measures four times: once before fitting, and at two weeks, three months and six months post fitting. Self-report outcome measures at each assessment captured fatigue, listening effort, hearing handicap, auditory lifestyle, social participation restrictions and work, social and physical activity levels. Hearing-aid fitting led to a significant reduction in listening-related fatigue, but not general fatigue, in the intervention group compared to the control group. Additionally, social activity level increased and social participation restriction decreased significantly after hearing aid fitting in the intervention group compared to the control group. No significant interaction was found between working status and change in listening-related fatigue score. This study is the first to make longitudinal measurement of fatigue before and after first-ever hearing aid fitting and to identify an increase in social activity level after hearing aid fitting. These findings have important implications for future research and the clinical practice of hearing aid fitting.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04875117Funding StatementThis work was supported by the Medical Research Council [grant numbers MR/R502169/1, MR/S003576/1]; and by the Chief Scientist Office of the Scottish Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research received ethical approval from the West of Scotland Research Ethics Committee (18/WS/0030) and the NHS R&D (GN18EN073).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data involved in the study is available upon request to the corresponding author. ER -